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Abstract 
We report novel functions of the cell adhesion molecule E-cadherin in murine 
pluripotent cells. E-cadherin was highly expressed in mouse embryonic stem cells, 
and interference with E-cadherin caused differentiation. During cellular 
reprogramming of mouse fibroblasts by Oct4, Sox2, Klf4 and c-Myc, fully 
reprogrammed cells were exclusively observed in the E-cadherin positive cell 
population, and could not be obtained in the absence of E-cadherin. Moreover, 
reprogrammed cells could be established by viral E-cadherin in the absence of 
exogenous Oct4. Thus, reprogramming requires spatial cues that crosstalk with 
essential transcription factors. The cell  adhesion molecule E-cadherin has important 
functions in pluripotency and reprogramming. 
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Introduction 
The regulation of pluripotency in mouse embryonic stem cells (mESCs) is a 
fascinating biological question with important implications both for basic science and 
for the therapeutic potential that is foreseen for such cells. The same holds true for 
induced pluripotent stem (iPS) cells of somatic origin. Both pluripotency and 
reprogramming are influenced by a number of cellular processes, such as regulation 
of transcription, signal transduction, regulation of miRNAs and epigenetic changes 
(reviewed in Jaenisch & Young, 2008). The concept of somatic cell reprogramming 
was initiated by the seminal finding that mouse embryonic fibroblasts (MEFs) can be 
converted to iPS cells by retroviral expression of four transcription factors, i.e. Oct4, 
Sox2, Klf4, and c-Myc (Takahashi & Yamanaka, 2006). 
The cadherins are membrane-spanning proteins of adherens junctions that play 
critical roles in cell-cell contact formation. A switch from epithelial components, such 
as E-cadherin (Cadherin-1) expression, to mesenchymal can occur, termed epithelial-
mesenchymal transitions (EMT), which promotes the migration of cells in the 
development of many organs and in the metastasis of tumors (Heuberger & 
Birchmeier, 2010). Opposite mechanisms, mesenchymal-epithelial transitions (MET) 
are important in strengthening tissue integrity following migratory processes in 
embryonic development. The function of E-cadherin in cell-cell adhesion is also 
connected to various signaling pathways that relay information about cell interactions 
to the cytoplasm and the nucleus (Stepniak et al, 2009). In early mammalian 
development, E-cadherin-based cell-cell contacts are required for the integrity of the 
embryonic blastocyst, and deletion of the E-cadherin gene results in failure of cell 
compaction at this stage (Larue et al, 1994). 
In the present study, we show that E-cadherin is essential for the maintenance of 
pluripotency of mESCs, and that disturbance or loss of E-cadherin induces EMT. 
During reprogramming of MEFs to iPS cells, E-cadherin production is always 
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associated with the reprogramming process and, remarkably, exogenous expression of 
E-cadherin can replace the requirement of Oct4 during reprogramming. 
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Results and Discussion 
E-cadherin is required to maintain pluripotency of mESCs 
We compared the expression of E-cadherin in undifferentiated 129/Sv3 mESCs 
grown in the presence of leukemia inhibitory factor (LIF) and in differentiating cells. 
Quantitative RT-PCR showed significant downregulation of E-cadherin and the 
pluripotency genes Oct4 and Nanog five days after LIF withdrawal (Fig. 1A). 
Conversely, N-cadherin mRNA was upregulated. The protein levels of E-cadherin 
and Oct4 decreased significantly in differentiating mESCs, while N-cadherin 
increased as shown by Western analysis and immunofluoresence (Fig. S1A, B). 
Moreover, cells changed their morphology from compact colonies to scattered cells 
after LIF withdrawal (Fig. S1B). Thus, high E-cadherin expression associates with 
stem cell-like morphology of undifferentiated mESCs, whereas N-cadherin expression 
associates with reduced cell-cell contacts and differentiation. 
We next analyzed whether E-cadherin is functionally required for the maintenance 
of pluripotency. Indeed, downregulation of E-cadherin in mESCs by a retrovirus that 
expressed an E-cadherin shRNA (shEcad) led to changes of cell morphology from 
compact colonies to scattered cells in the presence of LIF (Fig. 1B) accompanied by a 
strong downregulation of stem cell-associated genes Oct4, Nanog, Dppa5 and Nr5a2 
(Fig. 1C). We tested the effect of blocking E-cadherin by a function-interfering 
antibody, DECMA-1 (Fig. S1B). Reduced staining for Oct4 and strong staining for N-
cadherin was observed, and cells displayed a scattered morphology. Protein levels of 
E-cadherin, Oct4 and Nanog were downregulated in shEcad-transfected mESCs (Fig. 
S1C). Our results thus demonstrate that E-cadherin is required to maintain the 
undifferentiated state of mESCs and that mESCs undergo an EMT upon 
differentiation.  
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E-cadherin is induced during reprogramming 
Reprogramming of MEFs through viral expression of Oct4, Sox2, Klf4, and c-Myc 
proceeds in a stepwise manner that gives rise not only to iPS cells, but also to 
intermediate cell states. We used this procedure to generate iPS cells and sorted for 
cells that expressed the stem cell marker SSEA-1 by FACS analysis (Fig. 2A). 12.5% 
SSEA-1 positive cells were obtained eight days after retroviral transduction, and these 
cells maintained SSEA-1 expression (Fig. S2A). Intriguingly, SSEA-1 positive cell 
clones expressed E-cadherin but not N-cadherin, as detected by immunofluoresence 
and Western blotting, whereas SSEA-1 negative cell clones were low in E-cadherin 
but high in N-cadherin (Fig. 2B, Fig. S2B). Nanog was expressed only in the SSEA-1 
positive cells, suggesting that these cells had undergone complete reprogramming. In 
line with the immunostaining, qRT-PCR analysis revealed that SSEA-1 positive cell 
clones expressed high levels of E-cadherin (Ecadhigh) and low levels of N-cadherin. 
SSEA-1 negative cell clones displayed low levels for E-cadherin mRNA (Ecadlow), 
but high N-cadherin (Fig. 2C). The Ecadlow cell clones exhibited residual expression 
of viral Oct4, Sox2, Klf4 and c-Myc and low levels of the endogenous genes, showing 
that the retroviral expression was not silenced (Fig. 2C, Fig. S2C). High levels of 
Oct4 were detected in all cell clones, whereas the pluripotency factors Nanog and 
Dppa5 were present only in Ecadhigh clones. 
We then tested Ecadhigh and Ecadlow clones for their differentiation capacity (Fig. 
2D). E-cadherin, Oct4, and Nanog mRNA levels were downregulated in Ecadhigh 
clones upon LIF withdrawal, and the mRNAs for N-cadherin and Msx2, a 
transcription factor that is upregulated early upon differentiation, were induced. 
Ecadlow cells showed no changes of expression of these genes upon LIF withdrawal. 
Protein levels of cadherins and pluripotency factors and cell morphologies in the 
presence and absence of LIF were confirmed (Fig. S2D and E). We then examined the 
capability of our cells to form embryoid bodies (EB) that are characteristic for 
pluripotent stem cells (Fig. S2E). Only Ecadhigh clones could form EBs. These results 
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demonstrate that E-cadherin-positive cells exhibit mESC-like properties, consistent 
with reprogramming and pluripotency, whereas Ecadlow cells are not reprogrammed. 
Ecadhigh cell clones formed teratomas and participated in embryonic 
development 
To analyze the differentiation potential of Ecadhigh and Ecadlow cells in vivo, we tested 
their capacity to form teratomas following subcutaneous injection in NOD/SCID 
mice. Ecadhigh cells formed large, differentiated tumors by day 12 (0.17 +/- 0.04 cm3; 
Fig. 2E) that exhibited epithelial, neuronal and mesenchymal (muscular) structures, 
comparable to the teratomas formed by mESCs (0.18 +/- 0.07 cm3). Expression 
profiles of these tumors were similar to those of mESC-derived teratomas (Fig. S2F). 
In contrast, Ecadlow cells produced very small tumors (0.04 +/- 0.04 cm3) without 
differentiated structures (Fig. 2E). Ecadlow tumors also did not express tissue-specific 
markers, which indicated that the specific tissues were not formed (Fig. S2F). 
Next we marked Ecadhigh and Ecadlow cells with a GFP-expression construct to 
allow detection during mouse development. When Ecadhigh cells were injected into 
mouse blastocysts, chimerism was observed in different organs of newborn pups, as 
shown by the expression of GFP (Fig. 2F). Ecadlow cells did not participate in 
embryonic development. Taken together, our data demonstrate that high expression of 
E-cadherin and absence of N-cadherin are hallmarks of fully reprogrammed iPS cells, 
and that only these cells form teratomas and contribute to embryonic development.  
Conditional deletion of E-cadherin in Ecadflox/flox MEFs prevents reprogramming 
We isolated MEFs from mouse embryos that harbored two floxed E-cadherin alleles, 
Ecadflox/flox (Boussadia et al, 2002). Cre-mediated deletion of E-cadherin was achieved 
by the treatment of cultured cells with His-tat-NLS (HTN)-cre, a membrane-
penetrable Cre recombinase, which resulted in a strong reduction of E-cadherin-
positive cells (Fig. 3A). We then attempted to induce reprogramming of these cells 
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into iPS cells by viral transduction of OSKM and followed colonies by morphological 
inspection. An 80% reduction of colony numbers was found (Fig 3B). These MEFs 
were also analyzed for expression of pluripotency genes (Fig. 3C). Both Oct4 and 
Nanog were expressed at low levels (40% and 15%, respectively) in the HTN-cre-
treated MEFs. We conclude that reprogramming is severely impaired in the absence 
of E-cadherin and that an MET with an induced expression of E-cadherin is required 
for somatic nuclear reprogramming. 
Forced expression of E-cadherin in MEFs can overcome the requirement of Oct4 
for reprogramming 
We examined systematically, whether the expression of exogenous E-cadherin 
influences the overall efficiency of reprogramming and may even replace one of the 
OSKM factors during cellular reprogramming. Transduction of MEFs with the E-
cadherin-expressing retrovirus, pMXs-Ecad, led to a strong increase of E-cadherin 
expression, as observed for the other pluripotency factors (Fig. S3A). The analysis of 
the reprogramming efficiency with different combinations of pluripotency factors and 
E-cadherin revealed that E-cadherin did not induce a general increase in 
reprogramming efficiency, as measured by SSEA-1 expression or alkaline 
phosphatase (AP) activity (Fig. S3B, C). 
We also tested single cell clones that were produced by different factor 
combinations and scored them for the generation of those with iPS cell-like 
morphology (Fig. 4A). Intriguingly, the pMXs-Ecad retrovirus in combination with 
Sox2, Klf4 and c-Myc (ESKM), i.e. without Oct4, produced cells with the typical 
morphology of pluripotent iPS cells (Fig. 4B), although at a lower frequency than 
with OSKM (Fig. S4A). When E-cadherin was omitted in the SKM combination, cell 
clones of this morphology were rarely found (Fig. 4B). Cell clones from ESKM and 
SKM combinations were cultivated for several passages and characterized. 
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Remarkably, ESKM cell clones were positive for endogenous Oct4 (Fig. 4C), Nanog 
and SSEA-1, which was not observed in SKM cells (Fig. S4B).  
Independent ESKM clones (#1,2,3) indeed showed elevated mRNA expression for 
E-cadherin and for the pluripotency genes Oct4, Nanog, Dppa5, and Nr5a2, while 
expression of N-cadherin was not observed (Fig. 4D). Viral E-cadherin expression 
was present two days after the infection, but was subsequently silenced. E-cadherin 
and Oct4 proteins were produced in ESKM clones, while N-cadherin protein was 
absent (Fig. S4C). ESKM-derived cell clones were able to form EBs (Fig. S4D) and 
showed expression of genes for endodermal (FoxA2), neuronal (Nestin) and 
mesodermal (α-SMA) lineages (Fig. S4E). Moreover, ESKM-reprogrammed iPS cells 
formed teratomas in NOD/SCID mice with epithelial, neuronal and muscular 
structures (Fig. 4E, Fig. S4F). SKM clones exhibited only small cell lumps without 
significant growth or specific tissue structure formation. These data demonstrate that 
iPS cells can be derived in the presence of E-cadherin instead of Oct4 and showed all 
characteristics of pluripotent, reprogrammed cells. 
Our analysis is focused on understanding the function of E-cadherin, both in EMT 
of embryonic stem cells during differentiation, and in MET of fibroblasts during iPS 
cell reprogramming. First, we demonstrate that interference with E-cadherin in 
mESCs caused EMT and differentiation. Another study also shows that E-cadherin is 
a critical determinant in the conversion of mouse epiblast stem cells to pluripotent 
mESCs (Chou et al, 2008). These data prove that E-cadherin plays a crucial role in the 
maintenance of ESC pluripotency and the compact shape of the colonies. Second, in 
reprogramming of mouse embryonic fibroblasts by the four Yamanaka factors 
(OSKM), we found that iPS cells were exclusively E-cadherin positive, and could not 
be obtained in Ecadflox/flox cells following Cre-mediated deletion of E-cadherin. This 
latter finding is particularly important, since it is based on genetic evidence and not on 
overexpression of factors or treatment with inhibitors. For instance, shRNA viruses 
directed against E-cadherin could prevent iPS cell reprogramming and chemical 
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intervention leading to upregulation of E-cadherin promoted somatic cell 
reprogramming (Chen et al, 2010). Recently, E-cadherin has also been found to be 
upregulated during reprogramming in global expression analyses (Samavarchi-
Tehrani et al, 2010) and in a screen for cell adhesion molecules (Li et al, 2010). In our 
reprogramming system, overexpression of E-cadherin alone could not enhance the 
efficiency of iPS cell production; such an effect was recently reported (Chen et al, 
2010). Reprogramming might thus also depend on the delivery system and the cellular 
context used. Taken together, these findings add entirely novel aspects to the 
processes of nuclear reprogramming: next to transcriptional networks (Jaenisch & 
Young, 2008), epigenetic changes (Hochedlinger & Plath, 2009) and changes in 
miRNA expression (Judson et al, 2009), apparently also spatial cues based on the 
function of E-cadherin are of importance. 
Third, our finding that the expression of E-cadherin is able to replace the 
exogenous transcription factor Oct4, adds an attractive new layer to our understanding 
of reprogramming. It shows that iPS cell reprogramming is not just a nuclear event, 
but that spatial cues also participate, and that these crosstalk with essential 
transcription factors in a novel fashion. Specific cell-cell contacts of pluripotent cells 
appear to tie directly into the pluripotent transcription factor circuit, which lastly 
influences the master transcription factor, Oct4. Signaling events downstream of E-
cadherin may provide a competent stimulus to upregulate endogenous Oct4. It is 
tempting to speculate that E-cadherin could control Oct4 through binding and 
sequestering β-catenin, i.e., by modulation of canonical Wnt signaling. It has been 
shown previously that inhibition of GSK3 enhances the pluripotency during somatic 
reprogramming (Silva et al, 2008), and that both β-catenin and E-cadherin are targets 
of GSK3, which may regulate the stability of cell-cell adhesion (Lickert et al, 2000). 
Alternately, the effects of E-cadherin on induced pluripotency may also require the 
involvement of Rho-family GTPases (Fukata & Kaibuchi, 2001). Cadherins modulate 
the activities of RhoA family of GTPases and their downstream kinases such as Rock. 
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It has been shown that inhibition of Rock has a positive role on pluripotency of 
human embryonic stem cells (Watanabe et al, 2007). The elucidation of the molecular 
mechanisms that establishes the crosstalk between the cell surface and nuclear 
machinery, especially the regulation of Oct4, awaits further analysis. With these three 
parts of our investigation, we have discovered entirely new functions for the cell 
 adhesion molecule E-cadherin in pluripotency and reprogramming. 
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Material and Methods 
Plasmids 
Annealed small hairpin-forming oligos with the E-cadherin targeting sequence: 5’-
AGCTTAAAAAAGAACCTGGTTCAGATCAAATTCTCTTGAAATTTGATCTG
AACAGGTTCTGGG-3’ (top) and 5’-
GATCCCCAGAACCTGGTTCAGATCAAATTTCAAGAGAATTTGATCTGAAC
CAGGTTCTTTTTTA-3’ (bottom) were cloned into pMSCV (Clontech). For 
overexpression of E-cadherin, the coding sequence of mouse E-cadherin was 
introduced in the pMXs vector before. 
Cell culture 
129/Sv3 derived mESCs (from S. Noggle, NYSCF, New York) and established stable 
iPS cell lines generated were cultured on mitomycin C-treated (2mg/ml) mouse 
embryonic fibroblasts (MEF). MEFs were isolated according to standard procedures 
either from embryos of the mouse strain B6.129/Sv3-Cdh1tm2Kem/J (Ecadflox/flox), or 
from the outbreed strain Cf1 (Takahashi & Yamanaka, 2006). 
Generation of iPS cells 
Generation of induced pluripotent stem cells was performed as described previously 
(Takahashi & Yamanaka, 2006). In brief, 5 x 106 Plat-E cells/10cm dish were seeded 
one day before transfection with pMXs-based retroviral vectors (Oct4, Sox2, Klf4 and 
c-Myc; all from Addgene) using calcium phosphate precipitation in Plat-E medium 
supplemented with 25 µM chloroquine as previously described. 
Cell-based assays 
Immunofluoresence; Cells were fixed for 15 min with 100% ice-cold methanol, 
washed for 15 min at room temperature with PBS, 0.1% Triton-X-100 and blocked 
for 15 min in PBS with 2% BSA and 2% horse serum (blocking solution). The cells 
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were incubated with primary antibodies (as indicated) in blocking solution washed 
with PBS, 0.1% Triton-X-100 and incubated for 40 min with respective secondary 
antibodies. DAPI nuclear counter stain was used as described by the manufacturer 
(Sigma, D-9542). Stained cells were imaged following standard procedures on a Leica 
LAS AF 6000 Deconvolution. 
Quantitative real-time PCR and Western analysis; These assays were performed as 
described before (Diecke et al, 2008). Antibodies used were against E-cadherin (BD 
and DECMA-1), N-cadherin (BD), Oct4 (Santa Cruz), Nanog (abcam), α-Tubulin 
(Sigma) and SSEA-1 (R&D). Secondary antibodies were used (Zymed and Jackson 
Laboratories). 
Flow cytometry and FACS; Flow cytometric analysis of cells was performed using 
antibodies indicated. For flow cytometry and fluorescence-activated cell sorting 
(FACS), cells were washed once with ice cold PBS, harvested and centrifuged. The 
cell pellets were resuspended in wash puffer (20 % FBS/Hanks balanced salt solution, 
1 mM CaCl2, Mg2+ and Ca2+ free). For labeling 2.5 x 105 cells were diluted in a total 
volume of 200 µl and primary antibodies (15 min, 4°C) were added, followed by 
secondary antibodies (5 min, 4°C). Labeled cells were analyzed using FASCalibur or 
sorted using FACSAriaII (both BD). 
Cre-recombinase treatment; Cells were treated with 3 µM purified, membrane-
penetrable His-tat-NLS (HTN)-cre for 24 hours as described previously (Peitz et al, 
2002). 
Animal-based assays 
Teratoma formation and histological analysis; 1 x 106 Cells were injected 
subcutaneously in NOD/SCID mice for teratoma formation as described (Takahashi 
& Yamanaka, 2006). Tumors were grown for 21 days and surgically dissected, 
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tumors were stained with haematoxylin and eosin (H&E) and biopsies were taken for 
RT-PCR analysis. 
Blastocyst injection; For blastocyst injection, iPS cells (10-12 cells) stably transfected 
with the GFP expressing plasmid MP71-gfp were injected either at blastocyst stage of 
developing embryo. Blastocysts were transferred in uteri of surrogate mothers. Pups 
were analyzed for GFP positive spots 2 days after birth. 
Supplementary information is available. 
 - 15 - 
Acknowledgments 
The authors thank A. Kirschner and M. Mühlbauer for technical assistance and A. 
Klaus, H.-P. Rahn, B. von Eyss, K. Eckert and I. Fichtner and B. Jerchow and K. 
Becker for technical help. We express our appreciation to R. Hodge, U. Ziebold, I. 
Ibanez-Tallon and M. Gossen for critical reading of the manuscript. 
A BMBF grant in the joined project START-MSC (01GN0941) and an EC Marie 
Curie IRG (FP6-021407) supported this work. 
The authors have no conflicting financial interests. 
 - 16 - 
References 
Boussadia O, Kutsch S, Hierholzer A, Delmas V, Kemler R (2002) E-cadherin is a survival factor for 
the lactating mouse mammary gland. Mech Dev 115(1-2): 53-62 
Chen T, Yuan D, Wei B, Jiang J, Kang J, Ling K, Gu Y, Li J, Xiao L, Pei G (2010) E-cadherin-
mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells 28(8): 
1315-1325 
Chou YF, Chen HH, Eijpe M, Yabuuchi A, Chenoweth JG, Tesar P, Lu J, McKay RD, Geijsen N 
(2008) The growth factor environment defines distinct pluripotent ground states in novel blastocyst-
derived stem cells. Cell 135(3): 449-461 
Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA (2008) Tcf3 is an integral component of 
the core regulatory circuitry of embryonic stem cells. Genes Dev 22(6): 746-755 
Diecke S, Quiroga-Negreira A, Redmer T, Besser D (2008) FGF2 signaling in mouse embryonic 
fibroblasts is crucial for self-renewal of embryonic stem cells. Cells Tissues Organs 188(1-2): 52-61 
Fukata M, Kaibuchi K (2001) Rho-family GTPases in cadherin-mediated cell-cell adhesion. Nat Rev 
Mol Cell Biol 2(12): 887-897 
Heuberger J, Birchmeier W (2010) Interplay of cadherin-mediated cell adhesion and canonical Wnt 
signaling. Cold Spring Harb Perspect Biol 2(2): a002915 
Hochedlinger K, Plath K (2009) Epigenetic reprogramming and induced pluripotency. Development 
136(4): 509-523 
Jaenisch R, Young R (2008) Stem cells, the molecular circuitry of pluripotency and nuclear 
reprogramming. Cell 132(4): 567-582 
Judson RL, Babiarz JE, Venere M, Blelloch R (2009) Embryonic stem cell-specific microRNAs 
promote induced pluripotency. Nat Biotechnol 27(5): 459-461 
Larue L, Ohsugi M, Hirchenhain J, Kemler R (1994) E-cadherin null mutant embryos fail to form a 
trophectoderm epithelium. Proc Natl Acad Sci U S A 91(17): 8263-8267 
Li R, Liang J, Ni S, Zhou T, Qing X, Li H, He W, Chen J, Li F, Zhuang Q, Qin B, Xu J, Li W, Yang J, 
Gan Y, Qin D, Feng S, Song H, Yang D, Zhang B, Zeng L, Lai L, Esteban MA, Pei D (2010) A 
mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse 
fibroblasts. Cell Stem Cell 7(1): 51-63 
Lickert H, Bauer A, Kemler R, Stappert J (2000) Casein kinase II phosphorylation of E-cadherin 
increases E-cadherin/beta-catenin interaction and strengthens cell-cell adhesion. J Biol Chem 275(7): 
5090-5095 
Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F (2002) Ability of the hydrophobic FGF and basic 
TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic 
engineering of mammalian genomes. Proc Natl Acad Sci U S A 99(7): 4489-4494 
Samavarchi-Tehrani P, Golipour A, David L, Sung HK, Beyer TA, Datti A, Woltjen K, Nagy A, 
Wrana JL (2010) Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in 
the initiation of somatic cell reprogramming. Cell Stem Cell 7(1): 64-77 
Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, Smith A (2008) Promotion of 
reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6(10): e253 
 - 17 - 
Stepniak E, Radice GL, Vasioukhin V (2009) Adhesive and signaling functions of cadherins and 
catenins in vertebrate development. Cold Spring Harb Perspect Biol 1(5): a002949 
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult 
fibroblast cultures by defined factors. Cell 126(4): 663-676 
Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa 
S, Muguruma K, Sasai Y (2007) A ROCK inhibitor permits survival of dissociated human embryonic 
stem cells. Nat Biotechnol 25(6): 681-686 
 
 - 18 - 
Figure Legends 
Figure 1. E-cadherin expression is required for maintenance of pluripotency 
(A) Quantitative real-time RT-PCR for E-cadherin (Ecad), Oct4 and Nanog and N-
cadherin in 129/Sv3 mESCs, undifferentiated control (+LIF Ctl) or differentiated in 
the absence of LIF (as indicated in days (d)). The mRNA expression levels were 
normalized to β-actin, and values for undifferentiated mESCs were set to 1. Values 
are presented in duplicates with median values indicated by bars and higher values 
indicated by error bars. (B) Immunofluorescence of 129/Sv3 cells for Ecad, Oct4 and 
Nanog, 4 days after viral transduction with a pMSCV vector (empty) or a vector 
constitutively expressing shRNA against E-cadherin (shEcad). Nuclei were stained 
with DAPI. Magnification 400x, bars 50 µm. (C) Real-time RT-PCR of 129/Sv3 
mESCs in LIF not transduced (mock) or transduced as in (B). mRNA levels for Ecad, 
Oct4, Nanog, Dppa5 and Nr5a2 are shown as in (A). 
Figure 2. SSEA-1 positive iPS cells express endogenous pluripotency genes, form 
teratomas and contribute to blastocysts forming chimeras 
(A) MEFs were retrovirally transduced with the four factors Oct4, Sox2, Klf4 and c-
Myc (OSKM). Sorting for SSEA-1 was performed. Mesenchymal-to-epithelial 
transition, MET. (B) Characterization of established cell clones derived from SSEA-1 
positive (Ecadhigh) cells and SSEA-1 negative (Ecadlow) cells, in comparison to 
129/Sv3 mESC. Immunofluorescence for Ecad (cyan), SSEA-1 (red) and Nanog 
(green) are shown. Nuclei were stained with DAPI (blue). Ncad (red) was analyzed in 
independent clones. Magnification 400x, bars 50 µm. (C) Agarose gel electrophoresis 
of RT-PCR products for marker expression of three stable Ecadhigh iPS cell clones 
(#4, #6 and #11) in comparison to cells of an Ecadlow clone (#1, Ecadlow), 129/Sv3 and 
MEFs. SSEA-1 expression was determined by flow cytometry and is indicated (+/–). 
Expression of Ecad, Ncad, viral (v) and total (t) Oct4, Nanog and Dppa5 was 
analyzed. β-Actin was the loading control. (D) Quantitative real-time RT-PCR 
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analysis of spontaneously differentiated Ecadhigh iPS (Ecadhigh) cells, Ecadlow cells and 
129/Sv3 cells grown for 4 days in presence or absence of LIF. mRNA levels for Ecad, 
Oct4 and Nanog (left panel) and Ncad and Msx2 (right panel) are presented as in Fig. 
1A and related to Ecadhigh iPS cells in LIF set to 1. (E) Morphology of tumors derived 
from Ecadhigh#4 cells (1) or Ecadlow cells (5) in NOD/SCID mice (n=3/cell clone). 
Histological analysis of tissue sections by haematoxylin and eosin (H&E) staining of 
differentiated tumors (Ecadhigh#4) comprising epithelial (2), neuronal (3) and muscle 
derived (4) structures, or of a undifferentiated tumor (Ecadlow#1; 6). Magnification 
25x (H&E staining), bars 500µm. (F) Chimera formation following injection of GFP-
labeled Ecadhigh#11 cells in mouse blastocysts (n=3/cell clone) and analysis of 
newborn pups (1) for GFP positive areas by fluorescence (2). GFP-labeled organs like 
the gut (3) were detected by fluorescence (4). No GFP-labeled Ecadlow cells were 
visible (5 and 6). 
Figure 3. Loss of E-cadherin expression reveals its necessity during the induced 
pluripotency process in murine fibroblasts 
(A) Treatment of Ecadflox/flox MEFs or wild-type (wt) MEFs with HTN-cre for 24 
hours and transduction of OSKM. Ecad protein levels were detected in whole cell 
lysate by Western blotting. (B) Number of colonies observed following no treatment 
(white bars) or HTN-cre treatment (black bars) of cells treated as in (A) and viral 
transduction of the factors OSKM. The number of colonies is shown in % to untreated 
controls. (C) Quantitative real-time RT-PCR analysis of expression of Ecad, Ncad, 
Oct4, Nanog and Dppa5 in Ecadflox/flox MEFs treated as in (A) after induction of 
pluripotency by OSKM. Expression levels for untreated, virally transduced cells are 
set to 1. 
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Figure 4. E-cadherin is capable of replacing Oct4 in the induction of stem cells in 
somatic cell reprogramming 
(A) Derivation of ESKM-iPS cell clones following viral transduction of MEFs in 
presence of Ecad but absence of Oct4. Transduced MEFs were seeded and ES-cell 
like colonies were visible after 12-14 days. Primary clones were isolated without 
sorting and propagated. (B) Morphology of two independent primary clones 
photographed 12 days after viral transduction of MEFs with ESKM (upper panel) or 
SKM (lower panel). Primary clones were isolated and cultured for 4 days on feeder 
cells. Morphology of ESKM or SKM cells is shown in the right panels. (C) 
Immunofluorescence analysis of established ESKM (#2, #3) and SKM cells for 
expression of Oct4. Nuclei were stained with DAPI. Magnification 400x, bars 50 µm. 
(D) Agarose gel electrophoresis of RT-PCR products was performed with ESKM 
clones (#1, #2 and #3), ESKM induced MEFs 2 days after infection (2d pi), SKM 
subcloned cells (SKM), SKM infected MEFs (2d pi), OSKM-derived iPS cells and 
OSKM induced MEFs (2d pi). Expression levels of viral (v) and total (t) Ecad, Ncad, 
viral (v) and total (t) Oct4, Nanog, Dppa5 and Nr5a2 of cells were determined. β-
Actin was the loading control. (E) Whole morphology of tumors derived from ESKM-
derived iPS cells (ESKM#2; 1) or SKM-derived cells (5; n=3/cell clone). Histological 
analysis of tissue sections by H&E staining of differentiated tumors (ESKM#2) 
comprising epithelial (2), neuronal (3) and muscle derived (4) structures or of a 
undifferentiated tumor (SKM; 6). Magnification 25x (H&E staining), bars, 500µm. 
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Supplementary Material: 
Table for primer sequences used in quantitative real-time PCR: 
Gene Accession No. Sequence 
Ecad-total-s NM_009864 TTGAGGCCAAGCAGCAATACATCC 
Ecad-total-as  AGATGTGATTTCCTGACCCACACC 
Ecad-endo-s NM_009864 CTCAGTGTTTGCTCGGCGTCTGC 
Ecad-endo-as  CAGGACATGGCCTCTCTCCAGGT 
Ecad-viral-s  ACGGCGGTGGTGAGGACGACTAG 
Ecad-viral-as  ATCCTGTTTGGCCCATATTCAGCT 
Ncad-s NM_007664 TTGCTTCTGACAATGGAATCCCGC 
Ncad-as  AAGGAAAGATCAAACGCGAACGGC 
Klf4, total-s NM_010637 CACCATGGACCCGGGCGTGGCTGCCAGAAA 
Klf4, total-as  TTAGGCTGTTCTTTTCCGGGGCCACGA 
Klf4, endo-s NM_010637 GCGAACTCACACAGGCGAGAAACC 
Klf4, endo-as  TCGCTTCCTCTTCCTCCGACACA 
c-Myc, total-s NM_010849 CAGAGGAGGAACGAGCTGAAGCGC 
c-Myc, total-as  TTATGCACCAGAGTTTCGAAGCTGTTCG  
c-Myc, endo-s NM_010849 GACCTAACTCGAGGAGGAGCTGGAATC 
c-Myc, endo-as  AAGTTTGAGGCAGTTAAAATTATGGCTGAAGC 
Oct4, total-s NM_002701 CTGAGGGCCAGGCAGGAGCACGAG 
Oct4, total-as  CTGTAGGGAGGGCTTCGGGCACTT   
Oct4, endo-s NM_002701 TCTTTCCACCAGGCCCCCGGCTC  
Oct4, endo-as  TGCGGGCGGACATGGGGAGATCC 
Oct4, viral-s  AAGAACCTAGAACCTCGCTGGAAAGG 
Oct4, viral-as  CTGTAGGGAGGGCTTCGGGCACTT 
Sox2, total-s NM_011443 GGTTACCTCTTCCTCCCACTCCAG 
Sox2, total-as  TCACATGTGCGACAGGGGCAG 
Sox2, endo-s NM_011443 TAGAGCTAGACTCCGGGCGATGA 
Sox2, endo-as  TTGCCTTAAACAAGACCACGAAA 
Afp-s NM_007423 AATGACTAGCGATGTGTTGGCTGC 
Afp-as  TTCATGTGCTTTGCAACTCTCGGC 
Brachyury (T)-s NM_009309 ACCACCGCTGGAAATATGTGAACG 
Brachyury (T)-as   AACTCTCACGATGTGAATCCGAGG 
β-Actin-s NM_007393  TCGTGCGTGACATCAAAGAGAAGC 
β-Actin-as  ATGGATGCCACAGGATTCCATACC 
Dppa5-s  NM_025274  GAAATATCTGTTTGGCCCACAGGG 
Dppa5-as  GCCATGGACTGAAGCATCCATTTAGC 
GATA4-s NM_008092 TCACAAGATGAACGGCATCAACCG 
GATA4-as  GCAGGCATTACATACAGGCTCACC 
Isl-1-s NM_021459 TGATTTCCCTGTGTGTTGGTTGCG 
Isl-1-as  ATCACGAAGTCGTTCTTGCTGAAGCC 
Krt8-s NM_031170 AGCATTCATACGAAGACCACCAGC 
Krt8-as  TTGGACACGACATCAGAAGACTCG 
Mef2c-s NM_025282 AGCAGCAGCACCTACATAACATGC 
Mef2c-as  ATGCGCTTGACTGAAGGACTTTCC 
MMP2-s NM_008610  AGATGCAGAAGTTCTTTGGGCTGC 
MMP2-as  AAAGCATCATCCACGGTTTCAGGG 
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Msx2-s NM_013601 AAATCTGGTTCCAGAACCGAAGGG 
Msx2-as  CATGGTAGATGCCATATCCAACCG 
Myl7-s NM_022879 TTCAGCTGCATTGACCAGAACAGG 
Myl7-as  TGAGGAAGACGGTGAAGTTGATGG 
Nanog-s NM_028016 AACCAAAGGATGAAGTGCAAGCGG 
Nanog-as  TCTGGTTGTTCCAAGTTGGGTTGG 
Nestin-s NM_016701 AACAGAGCAAGATGAGGACAGAGC 
Nestin-as  TCTTTGCCTTCACACTTTCCTCCC 
Nr5a2-s NM_030676 ACACAGAAGTCGCGTTCAACAACC 
Nr5a2-as  TAGTTGCAAACCGTGTAGTCCAGC 
Sox1-s NM_009233 ATGCACAACTCGGAGATCAGCAAGC 
Sox1-as  AGTACTTGTCCTTCTTGAGCAGCG 
Sox17-s NM_011441 ATGTAAAGGTGAAAGGCGAGGTGG 
Sox17-as  ATCTTGCTTAGCTCTGCGTTGTGC 
Tbx5-s NM_011537 CAAATGGTCCGTAACTGGCAAAGC 
Tbx5-as  ACGCAGTGTTCTTTGAACCGAACC 
TropT2-s NM_001130174 TCCAACATGATGCACTTTGGAGGG 
TropT2-as  AGGTTGTGAATACTCTGCCACAGC 
 
PCR primers were designed with http://eu.idtdna.com/Scitools/Applications/ 
Primerquest/ using the whole coding sequence of the target genes (NCBI). Primers 
were designed as follows: Primer size 20 – 27 bp; TM 58 – 62 °C; GC% 35 – 65; 
Product size 150 – 250 bp; GC Clamp 2.  
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Supplementary Figures and Results 
Supplementary Figure 1. Reduction of E-cadherin results in loss of pluripotency 
marker expression 
(A) Analysis of protein extracts from 129/Sv3 cells undifferentiated or differentiated 
for 3, 5 or 7 days (d) with antibodies against Ecad, Ncad, Oct4 and as loading control 
α-Tubulin. 
Ecad and Oct4 protein levels are downregulated during differentiation while the level 
for Ncad strongly increased after 5 days of differentiation. 
(B) Immunofluorescence of 129/Sv3 mESCs undifferentiated (+LIF) and 
differentiated in absence of LIF for 7 days (-LIF) or transfected with siRNA against 
Ecad (Dharmacon, siEcad) for 3 days or a neutralizing antibody DECMA-1 for 3 days 
both in presence of LIF with antibodies against Ecad (light green fluorescence) and 
Ncad (red fluorescence) and Oct4 (dark green fluorescence) as indicated. DAPI 
nuclear staining (blue) was performed to visualize cell nuclei. Pictures were taken 
with a magnification of 400x. Bars, 50 µm. 
(C) Analysis of Ecad, Oct4 and Nanog protein levels by Western blotting of 129/Sv3 
mESCs in LIF not transduced (mock) or transduced with a pMSCV vector (empty) or 
a vector constitutively expressing shRNA against E-cadherin (shEcad). 
Undifferentiated and untreated 129/Sv3 cells reveal a strong Ecad and Oct4 staining 
but low staining for Ncad by immunofluoresence experiments. When cells were 
treated either with a neutralizing antibody DECMA-1 or siRNA against Ecad (siEcad) 
or kept in absence of LIF for 7 days (-LIF, 7d) a cadherin-switch was observed where 
mESCs start to express Ncad while expression of Ecad and Oct4 were lost. 
 4 
Supplementary Figure 2. SSEA-1 expression correlates with E-cadherin levels 
and pluripotency  
(A) Sorting of MEFs (10.000 cells) eight days after viral transduction (OSKM) using 
SSEA-1 (CD15) as cell surface marker into SSEA-1 positive (12.5% of total cells) 
and negative cells (87.5%) (left panel). Flow cytometry (right panel) of SSEA-1 
positive and negative cells cultured further on feeder cells for 8 days to established 
stable cell clones confirmed the presence and absence of SSEA-1 on SSEA-1pos cells 
and on SSEA-1neg cells, respectively. 
(B) High Ecad and Oct4 protein expression in stable SSEA-1 positive iPS cell clones 
(#4, #6 and #11) and SSEA-1 negative cells (#1). 
Ecad was highly expressed in SSEA-1pos cells but nearly absent in SSEA-1neg cells, 
whereas expression of Oct4 was visible in all cells even though Oct4 expression level 
was higher in SSEA-1neg cells due to expression of viral Oct4. 
(C) Analysis of mRNA expression levels of Ecadhigh and Ecadlow expressing cells, 
129/Sv3 mESCs and MEFs for viral, endogenous and total levels of Oct4, Sox2, Klf4 
and c-Myc. mRNA expression levels were normalized to the respective β-actin 
expression and values for MEFs were set to 1, the experiment was carried out in 
duplicate with the median values indicated by bars and the higher values indicated by 
an error bar. 
Levels of endogenous expressed Oct4, Sox2, Klf4 and c-Myc of Ecadhigh iPS cells 
were as high as in 129/Sv3 cells, whereas Ecadlow cells displayed low endogenous 
Sox2 levels and nearly no expression of endogenous Klf4 and c-Myc. Ecadlow cells 
showed high expression of viral genes since no silencing had occurred. 
(D) Protein levels of Ecad, Ncad, SSEA-1 and Oct4 in MEFs, 129/Sv3 mESCs, 
Ecadlow cells and Ecadhigh iPS cells cultured in presence or absence of LIF. Equal 
amounts of total protein were verified by α-Tubulin. 
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Differentiation of Ecadhigh cells is similar to 129/Sv3 mESCs. In presence of LIF, 
Ncad is not expressed, whereas Ecad is expressed on high levels. When LIF is 
withdrawn, Ecad level is reduced in both Ecadhigh and 129/ Sv3 cells but Ncad 
becomes upregulated. In addition, Oct4 and SSEA-1 level were also decreased in both 
cell lines. Interestingly, Ecadlow cells, bearing still high Ncad levels resulting from an 
inefficient MET process, are unable to undergo spontaneous differentiation. Ncad and 
Oct4 levels in Ecadlow cells were not changed upon LIF withdrawal. The high Oct4 
proteins levels in Ecadlow cells were from the virally expressed Oct4 gene. 
(E) Morphological changes of Ecadhigh iPS cells (1 and 4) and 129/Sv3 mESCs (3 and 
6) of cells grown in presence of LIF (1 and 3) and following spontaneous 
differentiation in absence of LIF for 4 days (4 and 6). Morphology of Ecadlow cells (2 
and 5) did not change under differentiating conditions when compared to growth in 
presence of LIF. EB formation of Ecadhigh cells (7) and 129/Sv3 cells (9) was 
observable, whereas Ecadlow cells did not form EBs (8). The magnification is 100x. 
Bars, 100 µm. 
Ecadhigh and 129/Sv3 cells display a round shaped morphology in presence of LIF 
whereas Ecadlow cells form loose flattened colonies. Upon spontaneous 
differentiation, round shaped colonies of Ecadhigh and 129/Sv3 cells form scattered 
colonies with cells migrating out from the edge of colonies. The morphology of 
Ecadlow cells did not change. Further, when Ecadhigh and 129/Sv3 cells were plated for 
EB formation, well shaped spheres become visible upon differentiation in suspension. 
When Ecadlow cells did not show formation of EBs, instead they form loose cell 
clumps and single floating cells. 
(F) Expression of differentiation marker genes of teratoma analyzed by agarose gel 
electrophoresis of RT-PCR products comprising representative markers of all three 
germ layers. Expression levels of E-cadherin (Ecad, epithelial), N-cadherin (Ncad, 
mesenchymal/neuroectoderm), Islet-1 (endoderm, neuroectoderm), Sox1 
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(neuroectoderm), Sox2 (neuroectoderm), Msx2 (mesenchymal/neuroectoderm), 
Cytokeratin 8 (Krt8, non-neural ectoderm), α-Fetoprotein (Afp, visceral and 
definitive endoderm), MMP-2 (mesoderm), Brachyury (T, pan-mesoderm), Mef2c 
(myogenic), Tbx5 (cardiomyogenic), GATA4 (definitive endoderm), Troponin T2 
(cardiomyogenic) and Myl7 (Myosin-light-chain 7, myogenic). 
This experiment revealed the presence of derivatives of endoderm (Ecad, Islet-1, 
Krt8, and Afp), mesoderm (MMP-2, T, Mef2c, GATA4, TropT2 and Myl7) but also 
ectoderm derived cells (Sox1, Sox2, Msx2 and Ncad) in Ecadhigh and 129/Sv3 derived 
tumors indicating that Ecadhigh cells were able to develop well differentiated tumors 
while Ecadlow cells were not. 
Supplementary Figure 3. E-cadherin overexpression during iPS cell induction 
did not increase efficiency 
(A) Western blot analysis (upper panel) and real-time PCR analysis (lower panel) of 
MEFs viral transduced with single pMXs-vectors carrying sequences of either Ecad, 
Oct4, Klf4 (Antibody: R&D, AF3158) Sox2 (R&D, AF2018), or c-Myc (Sigma, 
C3956). 
Transduced MEFs were analyzed for expression of indicated proteins and mRNAs, 2 
days after viral transduction. This analysis confirmed that all five factors were 
expressed in MEFs after viral transduction. 
(B) Flow cytometric analysis for SSEA-1 expression of MEFs following 8 days after 
viral transduction with different combinations of OSKM in presence or absence of 
pMXs-Ecad. SSEA-1 positive cells are shown in % of 10,000 analyzed cells. (C) 
Alkaline phosphatase assay of cells treated like in (B). For determination of alkaline 
phosphatase activity, cells were washed once with PBS and fixed with PBS/4% PFA. 
Cells were washed and alkaline phosphatase activity was visualized using both 
substrates NBT and BCIP. 
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To clarify whether Ecad overexpression during iPS cell-induction could improve 
efficiency of reprogramming in dependence of factor combinations, we performed 
flow cytometric analysis of induced MEFs transduced with different combinations 
(10) of four factors in absence or presence of Ecad. Number of SSEA-1 positive cells 
was decreased under most factor combinations. In addition, no significant increase in 
alkaline phosphatase positive cells colonies was observed in the presence of Ecad 
compared to colonies observed in the absence of Ecad. 
Supplementary Figure 4. Characterization of ESKM-iPS cell clones  
(A) Number of colonies of two independent transduction series and re-seeding in 
duplicates to 2 x 105 cells per 10 cm dish. Numbers were shown from duplicate 
experiments with the averages display as bars and the higher values displayed as error 
bars. 
Yields of iPS cell-colonies received from re-plated ESKM induced MEFs were much 
lower than those arising from OSKM. ESKM colonies were stable, expandable and 
morphologically indistinguishable from OSKM colonies. SKM-derived colonies were 
rare and immediately differentiated following re-plating. 
(B) Immunofluorescence analysis of established ESKM (#2, #3) and SKM cells for 
expression of Ecad, SSEA-1 and Nanog, as indicated. 
(C) Characterization of three established ESKM-clones in comparison to ESKM iPS 
cells, SKM-induced cells, 129/Sv3 cells and MEFs, respectively. Expression of Ecad, 
Ncad and Oct4 was determined by Western blotting as indicated, α-Tubulin was used 
as loading control. 
ESKM clones (#1,#2,#3) display high expression of Ecad and Oct4 as 129/Sv3 
mESCs, but no expression of Ncad indicating that these cells underwent proper MET 
and reprogramming, whereas Ecad and Oct4 are not expressed in SKM cells. 
 8 
(D) Pictures of EB formed by ESKM clones (#2 and #3). No EBs were detected for 
the SKM clones. 
(E) Outgrowth of EBs derived from ESKM clones (#2 and #3, Fig. S4D) was 
analyzed for marker genes of all three germ layers. Using immunofluorescence, 
expression of FoxA2 (endoderm; antibody from Abcam, AB40874), Nestin 
(ectoderm; antibody was a gift from C. Birchmeier) and α-smooth-muscle actin (α-
SMA; antibody from abcam, ab5694) was detectable in outgrown EBs of both iPS 
cell clones. DAPI was used for nuclear staining, the magnification is 400x. Bars, 50 
µm. 
ESKM cells of clones #2 and #3 have the potential to form derivatives of all three 
germ layers when differentiated via EB formation indicating that these cells reached 
the pluripotent stage. 
(F) Teratomas grown after injection of ESKM-iPS cells (clone#3, 1) in NOD/SCID 
mice. Sections were stained with H&E and typical epithelial/luminal structures were 
indicative for derivatives of endoderm (2). 
Formation of teratoma as described in Fig. 4, but with an additional clone ESKM#3. 




